bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,273 shares, an increase of ∞ from the May 31st total of 0 shares. Based on an average daily trading volume, of 488 shares, the short-interest ratio is currently 2.6 days.

bioAffinity Technologies Stock Up 13.1%

NASDAQ:BIAFW traded up $0.02 during mid-day trading on Thursday, reaching $0.15. The company’s stock had a trading volume of 871 shares, compared to its average volume of 2,431. bioAffinity Technologies has a 1 year low of $0.05 and a 1 year high of $0.81. The stock has a fifty day moving average of $0.21 and a 200-day moving average of $0.28.

About bioAffinity Technologies

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.